New cancer clinical trial: Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Published on: January 30, 2018 at 12:00PM
Condition:   Oropharynx Cancer
Interventions:   Drug: Cetuximab;   Radiation: Radiation Therapy
Sponsors:   University of Michigan Cancer Center;   VA Ann Arbor Healthcare System
Not yet recruiting
http://ift.tt/2BFD5kj